Cambridge Epigenetix

OverviewSuggest Edit

Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw using the 5-hydroxymethylcytosine (5hmC) epigenetic modification. The company is utilizing technologies, often based on fundamental chemistry, to detect the epigenetic biomarkers that will be most useful in clinical settings.

TypePrivate
Founded2012
HQLittle Chesterford, GB
Websitecambridge-epigenetix.com

Locations

Cambridge Epigenetix is headquartered in
Little Chesterford, United Kingdom

Location Map

Latest Updates

Employees (est.) (Nov 2019)60(+2%)

Key People/Management at Cambridge Epigenetix

Shankar Balasubramian

Shankar Balasubramian

Co-Founder and Director
Jason Mellad

Jason Mellad

Business Development Manager
Mike Booth

Mike Booth

Research Scientist
Show more

Cambridge Epigenetix Office Locations

Cambridge Epigenetix has an office in Little Chesterford
Show all (1)

Cambridge Epigenetix Financials and Metrics

Summary Metrics

Founding Date

2012

Cambridge Epigenetix total Funding

$56.5 m

Cambridge Epigenetix latest funding size

$30 m

Time since last funding

2 years ago

Cambridge Epigenetix investors

Cambridge Epigenetix's latest funding round in April 2018 was reported to be $30 m. In total, Cambridge Epigenetix has raised $56.5 m
Show all financial metrics

Cambridge Epigenetix Revenue

GBP

Net income (FY, 2012)

(86.2k)

Cash (31-Dec-2018)

16.0m
GBPFY, 2012

Pre tax profit

(86.2k)

Net Income

(86.2k)
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

482.1k202.3k1.5m967.3k10.8m5.0m16.0m

Accounts Receivable

77.3k1.7m67.2k31.2k7.2k7.9k

Inventories

56.9k35.7k54.6k80.3k20.7k129.7k

Current Assets

497.9k336.5k3.3m1.3m11.1m5.5m17.2m
GBPFY, 2012

Net Income

(86.2k)
GBPY, 2018

Financial Leverage

1.1 x
Show all financial metrics

Cambridge Epigenetix Online and Social Media Presence

Embed Graph

Cambridge Epigenetix Frequently Asked Questions

  • When was Cambridge Epigenetix founded?

    Cambridge Epigenetix was founded in 2012.

  • Who are Cambridge Epigenetix key executives?

    Cambridge Epigenetix's key executives are Shankar Balasubramian, Jason Mellad and Mike Booth.

  • How many employees does Cambridge Epigenetix have?

    Cambridge Epigenetix has 60 employees.

  • Who are Cambridge Epigenetix competitors?

    Competitors of Cambridge Epigenetix include Actinium Pharmaceuticals, Horizon Discovery and Quark Pharmaceuticals.

  • Where are Cambridge Epigenetix offices?

    Cambridge Epigenetix has an office in Little Chesterford.

  • How many offices does Cambridge Epigenetix have?

    Cambridge Epigenetix has 1 office.